Cannabis Report
Home > Boards > Canadian > Cannabis >

Abattis Bioceuticals Corp. (ATTBF)

ATTBF RSS Feed
Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/17/2018 2:09:22 PM - Followers: 365 - Board type: Free - Posts Today: 2



Welcome to Abattis Bioceuticals Corp.


Abattis Confirms Breakthrough Extraction Technology Capabilities

 

ATTBF – Abattis looks to become a leader in extraction with proprietary Raybot extraction technology Raybot has repurposed its industrial Preparative Chromatography Separation System, previously used in Tobacco, Pharma and Natural Food industries, specifically for implementation in the Cannabis industry.
Let us explain...





 
Notable Products Created with Raybot Technology:
Resveratrol | 98% purity
5-HTP | 99% purity
Ginkgo Biloba Extract | 24% purity
Inositol | 99% purity
Co-Enzyme Q10 | 98.5% purity

Source: https://www.raybottech.com
 

 
Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.
 

Biocell Labs Inc. - is a wholly-owned subsidiary focused on providing standardized pharmaceutical-grade products. Currently, the company has 13 proprietary formulations for out-licensing to cosmetic, nutraceutical and pharmaceutical companies.

Northern Vine Labs™, a subsidiary of Abattis, seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada, with existing cannabis processing, testing, and packaging facility located in Langley, British Columbia. In addition to these services, the company supports its operations by providing analytical services for Licensed Producers.

North American Bioextracts – is a retail distribution arm operating in Canada and Washington State focusing on cannabis, cannabis derivatives, and ancillary products like vaporizers. The company aims to use its proprietary extraction technologies to develop customized THC extract oils and CBD extract oils, as well as customized vaporizer flavors to enhance the end user’s experience.

Vergence Sales & Marketing Group – creates botanical formulations, medical marijuana and specialized health products for safe and effective solutions to pain caused by inflammation and mental ailments common to "modern lifestyle".


Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Within our other divisions Northern Vine, North American Bioextracts and Biocube we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

For more information, visit the Company's website at: www.abattis.com Executive Overview (PDF download file)





Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products.
Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.





“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”






We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.



Canada’s cannabis industry is expected to surpass $22 billion in size over the coming years, according to Deloitte, with over 140,000 registered medical marijuana patients today. With about 40 licensed producers under the ACMPR, the industry is expected to see a shortfall in supply given the 205% compound annual growth rate in registered patients since June of 2014 along with the near-term plans to legalize marijuana for recreational use.

 
Northern Vine Labs™ is getting ready for our launch.

Visit our website and join our community for updates and educational information.




 

Northern Vine Labs™ are now on Health Canada list for licensed dealers!
The following link shows a list of laboratories that have a current Dealers Licence under the Narcotic Control Regulations and who are licensed to conduct activities with cannabis:
https://www.canada.ca/en/health-canada/services/list-licensed-dealers.html





Northern Vine Labs™, a subsidiary of Abattis, seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada. The ability to legally work with Cannabis remains rare and highly specialized. Northern Vine Labs™ Controlled Substance License enables proprietary methods and services to be offered to currentlicensed producers within Canada’s existing Federal regulatory structure. It also offers Northern Vine Labs™ customers, including Abattis, the ability to formulate and develop new products containing cannabinoid ingredients in advance of the end to prohibition.




 

In partnership with the BC Institute of Technology (BCIT), Northern Vine Labs™ has been working to develop new and improved methods for the analysis of cannabis. This work is expected to be published by BCIT positioning NV Labs as the industry expert in analytical services which are substantially faster and more reliable than any other in Canada. Utilizing these proprietary methods, Northern Vine Labs will offer for sale its analytical reference standards enabling market participants to check quality and metrological traceability of products, to validate analytical measurement methods, and/or to support the proper calibration of instruments.
Northern Vine Labs™ operations under the CSL will include:
1. Analytical Services
2. Research and Development Services
3. Extraction to Support Analysis and R&D?
In future, NV Labs anticipates the opportunity to amend its license to include:
4. Extraction service for sale of extracted ingredients
5. Importation/Exportation

Analytical Services
Potency Testing Determining composition and concentration of various cannabinoid compounds
Moisture Analysis and Foreign Matter Testing
Microbiological Testing
Ensuring the safety of products by testing for levels of mold and bacteria.

The Cannabis Trade Alliance of Canada, which represents producers, said the new regime should provide for mandatory testing: 

“Mandatory laboratory testing of all cannabis products (potency and contaminants) – a critical step in the seed-to-sale process when considering public health, and should be the main objective in the legalized framework.”
 




 

Vergence Visionary Bioceuticals, a subsidiary of Abattis, is a team of nutraceutical marketing and brand specialists focused on innovative health products to penetrate the fast growing market for natural, safe and effective solutions to two of society’s unresolved and ubiquitous health issues: Pain caused by inflammation and mental ailments common to our modern lifestyle. Vergence is the exclusive exporter of 99.6%, organic and pure CBD Isolate out of Hong Kong and directly to the rest of the world. Together with a vast distribution network and custom product and branded formulations via Northern Vine Labs, Vergence aims to promote healthy living through natural remedies. Vergence is in possession of over 100 Natural Product Numbers (NPN's) as granted by Health Canada and plans to develop and distribute these products into global markets for end use.





Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis next year. While many licensed producers are focused on expanding capacity, the best opportunities may be those that can add value for existing licensed producers. These opportunities include those companies focused on higher value cannabis extracts. Read here why the proprietary extraction technology from Abattis represents an important breakthrough that investors shouldn’t ignore.




Chart source: The Value Case For Investing In The Cannabis Sector
 
Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).



OUTSTANDING COMMON SHARE DATA
There are an unlimited number of common shares without par value authorized for issue.

Issued & Outstanding (10/08/2017)The Company has 167,580,301 common shares issued and outstanding (source)
 

System for Electronic Document Analysis and Retrieval (SEDAR) - www.sedar.com

 

Abattis Bioceuticals Corporation
Address: 104 - 9295 198th Street | Langley, BC V1M 3J9 | Canada

As an investor, you are our partner and we take this relationship seriously.
Please contact us if you have any questions or if you would like to invest in Abattis

Brook Bellian | Corporate Communications (778) 883.7869 | bbellian@yhoo.com

Email: news@abattis.com
Website: www.abattis.com/index.php/investors
Twitter: mobile.twitter.com/abattis




Abattis Bioceuticals
Phone: (604) 336.0881

Northern Vine
Phone: 
(604) 336.0881 | (604) 371.3371 | (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China


 

22/12/2017 | Abattis Announced its Intent to Purchase Green Tree Therapeutics
18/12/2017 | Abattis Abattis Announces Expansion of Northern Vine Dealer’s License
12/12/2017 | Abattis Confirms Breakthrough Extraction Technology Capabilities
12/12/2017 | Abattis Successfully Closes Private Placement
11/06/2017 | Abattis Validates Lab Strategy, Sets Stage for Rapid Growth
11/01/2017 | Emerald Health Expands Capabilities with Northern Vine Labs Deal
10/26/2017 | Abattis Partnership with Emerald Health Therapeutics
10/19/2017 | Abattis Announces Private Placement
10/04/2017 | Abattis Strikes South Korea Distribution
09/20/2017 | Abattis Prepares for Growth in Extracts
09/15/2017 | Share Swap – Abattis Regain 100% Control Over Northern Vine
09/13/2017 | Important Update on Northern Vine and Sales Division
08/28/2017 | Breakthrough CBD-Based Sunscreen Formulation
08/23/2017 | Northern Vine Provides Update on Growth Targets
08/21/2017 | EXPERION Becoming Legal Cannabis Producer
08/11/2017 | Abattis Adds New Product Line to Subsidiary Vergence
08/09/2017 | Abattis Files Amended and Restated Financial Statements
07/25/2017 | Abattis Expands Its Asian Distribution Sales Channels
07/17/2017 | Abattis Obtains DTC Eligibility
07/15/2017 | Abattis Partners with the CSE & Stockpools
06/15/2017 | New Key Executive and Management Positions
06/13/2017 | Abattis Provides Company Update
06/07/2017 | Abattis Announces New Board Members
05/10/2017 | Northern Vine Labs Expands Its Sales Team
05/03/2017 | Official Launch of Northern Vine Laboratory
04/26/2017 | Abattis Signed Exclusive Destribution Agreement
04/10/2017 | Abattis Bioceuticals Announces New CEO
04/06/2017 | Abattis Gets Added to the Marijuana Index by MJIC
04/04/2017 | Near-term Legalization Puts Testing into Focus
03/27/2017 | Next Month - Legislation to Legalize Marijuana in CA
03/20/2017 | Dr. David Galvez - New Science Advisor of Northern Vine
03/13/2017 | Abattis Team Positions for Next Stage of Growth
03/07/2017 | LP Highlights Continued Need for Testing
02/24/2017 | Abattis Prepares to Launch Northern Vine Labs
02/24/2017 | Abattis Annual Report - September 30, 2016
02/14/2017 | Abattis Audit Update
02/08/2017 | Key Shortcomings in Canada's Cannabis Industry
02/03/2017 | Abattis Audit Update
12/16/2016 | Abattis Provides Corporate Update
12/09/2016 | $ 5 Million Facility with Aluminia Partners
11/15/2016 | Dr. Shuang Xie – Director and CTA
11/09/2016 | Licensing Deal and Brand Acouisition
11/07/2016 | Renewal of Health Canada Licence
11/02/2016 | Appointment of New Independent Director
10/24/2016 | Agreement to Acquire 100% of Experion
10/17/2016 | Experion Prepares for Construction
10/05/2016 | MOU with Global Damon Pharma of South Korea
10/03/2016 | Northern Vine Receives Controlled Substance Licence






If you want to add or to change something on this site - send a message to guay.
 
Cannabis Report
ATTBF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#32182   No sales until Oct 17 … This is grleroy 07/17/18 02:09:22 PM
#32181   Well the doom and gloom has ramped up dangerx 07/17/18 12:28:49 PM
#32180   ATTBF...092...Oversold Pincher Chart...Bullish Engulfing Reversal signal... georgie18 07/16/18 05:12:24 PM
#32179   Only talking point: dis done Att_for_life 07/13/18 01:51:38 PM
#32178   Abattis Bioceuticals: 3 Reasons We’re Wary JohnCM 07/13/18 01:46:34 AM
#32177   Wow! https://ih.advfn.com/p.php?pid=staticchart&s=NO%5EATTBF&t=37&p=3&dm=0&a JohnCM 07/13/18 01:41:34 AM
#32176   Same characters running Abattis appear in many other hasslethehoff 07/12/18 06:32:31 PM
#32175   Next support .08 ATVrider 07/12/18 12:14:17 PM
#32174   Can somebody provide any DD or talking points all4weed 07/12/18 12:36:22 AM
#32173   Kudos to hasseldahoff. Exceptional DD. You this good HorizenBull 07/08/18 01:06:09 AM
#32172   SHIT COMPANY RUN BY SHIT PEOPLE HorizenBull 07/07/18 07:58:59 PM
#32171   Sketchy....glad I got out around 26 cents rprimo 07/07/18 09:04:42 AM
#32170   Abattis Bioceuticals: 3 Reasons We’re Wary hasslethehoff 07/07/18 12:21:49 AM
#32169   Hey - take a look at my post StarFishPatrick 07/05/18 10:30:32 PM
#32168   https://el2.convertkit-mail2.com/c/0vurdlr53xtguxnmko/e0hph0/aHR0cHM6Ly9ncml6emx brainiac54 07/05/18 02:07:18 PM
#32167   YOU have to understand that reading PR’s pumped HorizenBull 07/05/18 01:03:05 PM
#32166   I’m conflicted on this point - it’s the StarFishPatrick 07/05/18 12:22:43 PM
#32165   I'm with ya Lvannoy88 07/03/18 03:36:02 PM
#32164   hey, if they go for another rally, then IRVINESULLY 07/03/18 11:53:07 AM
#32163   ATTBF iHub board appears to have a proud dangerx 07/02/18 08:43:37 PM
#32162   Paying themselves millions of shares almost monthly Then HorizenBull 07/01/18 03:12:03 PM
#32161   Abanante dumped 3.5mil shares in February. Scooped another HorizenBull 07/01/18 03:09:43 PM
#32160   https://m.canadianinsider.com/node/7?menu_tickersearch=Abattis+Bioceuticals+Corp HorizenBull 07/01/18 03:04:57 PM
#32159   You’re right Shady management at best here. Nothing HorizenBull 07/01/18 02:53:14 PM
#32158   Copy that. Goodbuddy4863 06/30/18 09:58:33 AM
#32157   I could like that Silver Harvest. IRVINESULLY 06/30/18 08:35:42 AM
#32156   thnx...disappeared and put my money I more stable IRVINESULLY 06/30/18 08:34:46 AM
#32155   There's a lengthy discussion about Abenante and Bridgemark hasslethehoff 06/30/18 02:46:54 AM
#32154   Yes it was in their plans but this oatsuzn 06/29/18 01:28:09 PM
#32153   This was always in their strategy. Look Lvannoy88 06/29/18 10:40:14 AM
#32152   I'm just looking this over...this doesn't make any sense. oatsuzn 06/29/18 12:16:47 AM
#32151   Can someone do some dd on xlabs? 10% cj 13 06/28/18 11:41:44 PM
#32150   This is extremely welcome news! Thanks for sharing Jaymeinnyc 06/28/18 10:32:47 PM
#32149   Abattis to Launch New Cannabis Lab in Ontario jcamp212 06/28/18 02:44:43 PM
#32148   Lab opening.... https://www.stockwatch.com/News/Item.aspx?bid=U-z7320692-U%3aAT Lvannoy88 06/28/18 02:00:23 PM
#32147   I agree with ya Irvine. Mid oct I’m SILVER HARVEST 06/27/18 09:01:26 PM
#32146   I will consider it. Goodbuddy4863 06/27/18 07:12:42 PM
#32145   10-4. Wondered why I had not see You in awhile. Goodbuddy4863 06/27/18 07:10:41 PM
#32144   Yes...I been looking just now. Goodbuddy4863 06/27/18 07:09:29 PM
#32143   well...you know, as many of us do, there IRVINESULLY 06/27/18 07:00:06 PM
#32142   thnx...losing money with a smile on my face! ROTF IRVINESULLY 06/27/18 06:56:21 PM
#32141   interesting...thnx..and no, I do not own blockstrain...just ATTBF IRVINESULLY 06/27/18 06:55:07 PM
#32140   I got some Friends in Blockstrain Technology[I am not] Goodbuddy4863 06/27/18 06:52:53 PM
#32139   Thanks..I have seen You on other Boards. Goodbuddy4863 06/27/18 06:50:14 PM
#32138   Copy that. Goodbuddy4863 06/27/18 06:48:46 PM
#32137   back at ya... :>) IRVINESULLY 06/27/18 06:48:25 PM
#32136   Good to hear that you got some of IRVINESULLY 06/27/18 06:47:15 PM
#32135   Wish You the best of Luck with all Goodbuddy4863 06/27/18 06:46:46 PM
#32134   I believe You as I am not current Goodbuddy4863 06/27/18 06:44:27 PM
#32133   $3 share would be a good price! ROTF... IRVINESULLY 06/27/18 06:39:07 PM
PostSubject